KIDNEY TRANSPLANTATION
Clinical trials for KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney transplant study tests easier drug routine
Disease control TerminatedThis study looked at whether a once-daily anti-rejection drug (EnvarsusXR) combined with azathioprine works as well as the standard twice-daily drug combo for kidney transplant patients. It included 20 adults getting a kidney for the first time. The study was stopped early, so re…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New drug aims to improve kidney transplant success
Disease control TerminatedThis study tested a new drug called TCD601 (Siplizumab) against a standard treatment (rATG) in 33 kidney transplant patients. The goal was to see if TCD601 is safe and how the body processes it, with the hope of preventing organ rejection. The study was terminated early, so resul…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Could a single treatment free kidney patients from daily pills?
Disease control TerminatedThis study tested a combination of an experimental drug (siplizumab), donor bone marrow cells, and mild chemotherapy in 4 kidney transplant recipients. The goal was to see if this approach could train the body to accept the new kidney without needing lifelong anti-rejection medic…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Kidney transplant drug showdown: which is safer Long-Term?
Disease control TerminatedThis study looked at kidney transplant patients to compare two drugs—sirolimus and tacrolimus—both given with another drug called mycophenolate mofetil. The goal was to see which combination caused fewer long-term problems like kidney damage, diabetes, or cancer. The study was st…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Ultrasound upgrade could catch kidney transplant trouble sooner
Diagnosis TerminatedThis study tested a special ultrasound technique that uses a contrast dye to get clearer images of a new kidney after transplant. The goal was to see if this method could help doctors detect early signs of kidney injury or rejection. The study included 20 adult kidney transplant …
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1 • Sponsor: University of Utah • Aim: Diagnosis
Last updated May 08, 2026 12:04 UTC